Nutratrade srl presents Equigluc, a new 100% natural product based on dry apple extract with 50% phlorizin suitable for reducing post-prandial glucose levels. The increase in blood glucose is a typical symptom of diseases that are grouped together under the name of metabolic syndrome, which are characterized not only by very high fasting blood glucose levels, but also by arterial hypertension and by triglyceride values higher than norm.
The hypoglycemic action of Equigluc is provided by Florizine, a natural glycoside present in apple and in the bark of fruit trees, inhibitor of enzymes and multienzymatic systems that require ATP, alkaline phosphatase and renal and intestinal phosphatases. Equigluc induces the blocking of intestinal glucose absorption and in addition to possessing a natural anti-oxidant effect, it promotes cell health, lowers blood glucose and uric acid levels, as well as cholesterol and visceral fat.
The targeted action of Equigluc is made possible by the inhibition of the sodium-glucose co-transporter 2 (SGLT2), a protein responsible for 90% of the reabsorption of glucose by the kidneys. In this way a significant lowering of glucose values is obtained due to a consequent increase in its excretion. Equigluc, by blocking the reabsorption of glucose in the renal tubules, determines its elimination from the body and thanks to this mechanism not only improves the glycemic compensation the acquisition of glucose but also reduces blood pressure with consequent well-being for the entire system cardio-circulatory.
Equigluc exploits the natural components present in apple to assist the action of insulin, an endogenous hormone with a hypoglycemic effect normally secreted by kidney cells, which is not produced in sufficient quantities in people with type 2 diabetes (insulin secretion deficiency ) or does not act satisfactorily (insulin resistance).
Equigluc therefore exploits physiological mechanisms to lower the glucose reabsorption capacity by the kidney with the aim of increasing urinary loss and reducing its assimilation. Equigluc can be used as an adjuvant for the treatment of type 2 diabetes and obesity, as it acts directly on the kidney and does not interfere with other blood glucose control mechanisms, it promotes the reduction of sugar reabsorption not only for high blood sugar but also in the presence of moderate blood sugar levels without inducing situations of hypoglycemia. Together with the elimination of excess glucose, Equigluc allows for an effective disposal of the calories deriving from it from a reduction in body weight.
The quality and natural origin of Equigluc is certified by analyzes conducted in Italian laboratories, which resulted in a gluten-free, allergen-free, BTSE / TSE-free, irradiation-free and GMO-free product. The content in Florizina was determined using the technique of high performance liquid chromatography (HPLC) which allows to identify the exact content of the hypoglycemic active, guaranteed the quality and action of this product.